When is unrelated-donor hematopoietic cell transplantation (HCT) indicated for aplastic anemia?

Updated: Jan 29, 2021
  • Author: Sameer Bakhshi, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Unrelated-donor HCT is currently justified only if the donor is a full match and only if immunosuppressive therapy fails (failure of ≥1 course of immunosuppressive therapy) or treatment as part of a clinical trial fails. [5]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!